Immutep Ltd.
(NASDAQ : IMMP)

( )
IMMP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 6.89%160.030.0%$1347.19m
AMGNAmgen, Inc. -0.13%249.621.3%$691.62m
NVAXNovavax, Inc. 3.43%201.3480.0%$571.11m
SNSSSunesis Pharmaceuticals, Inc. -1.50%7.880.7%$550.84m
ILMNIllumina, Inc. -1.26%398.073.5%$515.02m
GILDGilead Sciences, Inc. 0.63%65.301.0%$465.35m
REGNRegeneron Pharmaceuticals, Inc. 0.86%481.162.7%$431.65m
VRTXVertex Pharmaceuticals, Inc. 0.55%217.131.9%$373.76m
ALXNAlexion Pharmaceuticals, Inc. 1.02%155.292.0%$316.00m
BIIBBiogen, Inc. -0.15%265.791.7%$265.53m
BNTXBioNTech SE 2.28%132.600.0%$236.33m
EXASEXACT Sciences Corp. -0.67%127.1418.4%$192.79m
NBIXNeurocrine Biosciences, Inc. 2.24%95.054.9%$177.79m
CRSPCRISPR Therapeutics AG 1.85%123.110.6%$176.91m
TWSTTwist Bioscience Corp. 0.87%142.030.0%$150.98m

Company Profile

Immutep Ltd. is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma. The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.